Mebiopharm Co., Ltd
HomeSitemapNotes for UsageInquiry日本語
Introduction
Management Philosophy
Business Plan
Company Outline
Board Members
History
Research & Development
Products
Transferrin Products
Map
  Mebiopharm Co., Ltd. What's New
August 11, 2010

300million yen was invested through a private equity placement announced on August 11.


August 10, 2010

Mebiopharm makes a presentation about Clinical Development of Anticancer Drug in BioJapan2010 (Sept 29 - Oct 1 in Pacifico Yokohama).

August 1, 2010

"A study and development of evaluation methods of formulation and production to build up a scientific development strategy for drug formulation and production" by National Institute of Health Science that Mebiopharm takes part, is adoputed as the governmental program "Health and Labour Sciences Research Grants / Research on Publicly Essential Drugs and Medical Devices".


July 15, 2010

Article about MBP-426 in Nikkei Sangyo Shinbun

Link (only in Japanese)

May 18, 2010

Presentation at the annual meeting of The Japan Society of Drug Delivery System

Link (only in Japanese)

May 18, 2010

Office moved.

November 18, 2009

Presentation on Phase 1b Study result of MBP-426 at the AACR-NCI-EORTC International Conference in Boston

Link to the poster

September 10, 2009

Presentation in Japan Biotech Forum in London 2009

Link to the website

May 30, 2009

MBP-426 promising Phase I result to be presented at ASCO 2009

Link to the poster

February 04, 2009

Phase II trial for 2nd line Gastric plus GE junction starts in U.S

Nikkei Biotech online

 

 

Click here to see past articles

Copyright© 2010 Mebiopharm Co., Ltd. All Rights Reserved.